ThursdayFeb 01, 2024 1:14 pm

QualityStocksNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Poised with First-Mover Advantage in Class 1 and Class 3 Commercial Vehicles

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it continues to capitalize on its first-mover advantage in the U.S. market with production and deliveries of its Class 1 EV cargo vans and Class 3 EV trucks. Mullen began Class 3 vehicle production in August 2023 and Class 1 production in November 2023, with first vehicle deliveries in September 2023 and December 2023, respectively. “While many of the OEMs and new EV companies have launched their EVs with significant losses, Mullen is out-of-the-gate with a positive gross profit margin per vehicle,” said David Michery, CEO and…

Continue Reading

ThursdayFeb 01, 2024 12:00 pm

FinovateEurope 2024 To Feature Pioneering Fintech Innovations

Finovate is Europe’s leading fintech conference that offers a phenomenal platform for companies and executives. They come together at Finovate to discover and discuss innovative ideas and develop impactful connections in various fintech verticals. Get important insights as experts delve deep into vital and trending topics of the fast developing fintech world. At Finovate, you see the best operational strategies from financial influencers. Fintech firms and entrepreneurs must leverage this huge opportunity to develop networking ties with investors, bankers, and key financial innovators. Attendees get immense exposure as over 1,000 decision-makers with 100+ expert speakers and 500+ financial institutions will…

Continue Reading

ThursdayFeb 01, 2024 11:15 am

Turbo Energy (NASDAQ: TURB) Seeks to Help Facilitate Global Decarbonization Goals

The recent COP28 Conference laid out the world’s plans to both, phase out fossil fuels as well as triple ongoing investment in renewable energy technologies The dramatic increase in renewable energy demand, particularly amongst households, is a trend which Turbo Energy is seeking to capitalize on The launch of the company’s ‘SunBox’ home system provides end users with the ability to harness and make use of solar energy through a single, standalone product Turbo Energy recently announced the start of a distribution partnership with Solar360, a division of Spanish telecom giant, Movistar Speaking at the United Nation’s Climate Change Conference…

Continue Reading

ThursdayFeb 01, 2024 10:30 am

Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) CEO Discusses Preventative Measures to Reduce Risk of Data Leaks on “Weekly Hack” Segment

During the first three quarters of 2023, 32.23 million data breaches were exposed worldwide Sekur CEO Alain Ghiai's "Weekly Hack" segment explores preventative measures to lessen the likelihood of an attack or data leak The company's Swiss-hosted solutions offer individuals, businesses, and governments options for secure and private communications and internet security During the pandemic, data breaches worldwide spiraled out of control, with 284.34 million breaches in data recorded. Since then, the highest recorded data breach numbers came during the first three quarters of 2023, with 32.25 million data breaches exposed worldwide (https://ibn.fm/ZXWWU). This week's "Sekur Privacy & Sekur Security…

Continue Reading

ThursdayFeb 01, 2024 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces 2024 GLP-1 Human and Animal Studies Roadmap

Lexaria, a global innovator in drug delivery platforms, has laid down its GLP-1 human and animal studies roadmap for the 2024 calendar year This builds on the success of its human pilot study, which marked a successful undertaking for exploring its patented DehydraTECH(TM) technology for the improved delivery of the GLP-1 drug semaglutide, available commercially in the branded product Rybelsus(R) The company’s chronic dosing animal study and its second human pilot study will commence in Spring and run for 12 weeks. The third human pilot study will start in May or June These studies will evaluate DehydraTECH for the improved…

Continue Reading

ThursdayFeb 01, 2024 9:00 am

Astiva Health CEO Dr. Tri Nguyen Discusses Company’s Growth and Vision on The Bell2Bell Podcast

In a recent episode of the 'Bell2Bell Podcast' hosted by Stuart Smith, Astiva Health was spotlighted as a significant player in the Medicare Advantage Prescription Drug (“MAPD”) sector. The episode featured an exclusive interview with Astiva Health’s Co-Founder and CEO, Dr. Tri Nguyen, a renowned expert in internal medicine and cardiology. Listen to the full interview to hear Dr. Nguyen discuss Astiva Health’s journey since its inception in 2020 and its expansion plans. He shared insightful details about the company's expansion to Los Angeles, San Bernardino, and Riverside from January 1, 2024, marking a pivotal phase in transforming healthcare delivery.…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered